SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 10.18 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 8.34 |
| Book Value / Share | 0.62 |
| Price / Book | n/a |
| NCAV ($M) | -12.80 |
| NCAV / Share | -0.96 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.66 |
| Return on Assets (ROA) | -0.26 |
| Return on Equity (ROE) | -0.59 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.40 |
| Current Ratio | 0.65 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 19.97 |
| Assets | 41.11 |
| Liabilities | 32.77 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 48.80 |
| Operating Income | -12.18 |
| Net Income | -9.50 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -8.07 |
| Cash from Investing | -1.18 |
| Cash from Financing | 9.42 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 507,024 | 1,265,791 | 40.06 | |
| 40,623 | 174,060 | 23.34 | |
| 145,175 | 22,755 | 637.99 | |
| 154,064 | 482,848 | 31.91 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| HRTX – Heron Therapeutics, Inc. | ICCC – ImmuCell Corporation |
| IKT – Inhibikase Therapeutics, Inc. | IMMX – Immix Biopharma, Inc. |
| IMNM – Immunome, Inc. |
Financial data and stock pages provided by
Fintel.io